Back to Search Start Over

Non-mutagenic Ru(<scp>ii</scp>) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding

Authors :
Rodrigo S. Corrêa
Victor M. Deflon
Alzir A. Batista
Alessandro Desideri
Eliana Aparecida Varanda
Mariana Santoro de Camargo
Rone Aparecido De Grandis
Márcia Regina Cominetti
Silvia Castelli
Eduardo E. Castellano
Jéssica Emi Takarada
Monize M. da Silva
UniversitàTorVergatadi Roma
Universidade Federal de São Carlos (UFSCar)
Universidade Federal de Ouro Preto
Universidade Estadual Paulista (Unesp)
Universidade DeSão Paulo
Universidade de São Paulo (USP)
Source :
Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP, Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual), Universidade de São Paulo (USP), instacron:USP
Publication Year :
2019
Publisher :
Royal Society of Chemistry (RSC), 2019.

Abstract

Made available in DSpace on 2020-12-12T01:40:44Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-01-01 Herein we discuss five ruthenium(ii) complexes with good cytotoxicity against cancer cells. These complexes are named [Ru(tzdt)(bipy)(dppb)]PF6 (1), [Ru(mmi)(bipy)(dppb)]PF6 (2), [Ru(dmp)(bipy)(dppb)]PF6 (3), [Ru(mpca)(bipy)(dppb)]PF6 (4) and [Ru(2mq)(bipy)(dppb)]PF6 (5), where tzdt = 1,3-thiazolidine-2-thione, mmi = mercapto-1-methyl-imidazole, dmp = 4,6-diamino-2-mercaptopyrimidine, mpca = 6-mercaptopyridine-3-carboxylic acid, 2mq = 2-mercapto-4(3H)-quinazolinone, bipy = 2,2′-bipyridine and dppb = 1,4-bis(diphenylphosphino)butane. In vitro cell culture experiments revealed significant cytotoxic activity for 1-5 against MDA-MB-231, MCF-7, A549, DU-145 and HepG2 tumor cells, higher than that for the standard anticancer drug cisplatin. Compound/DNA interaction studies were carried out showing that 1-5 interact with DNA by electrostatic force of attraction or by hydrogen bonding. Moreover, the complexes interact, moderately and spontaneously, with human serum albumin (HSA) through the hydrophobic region. The five complexes are able to inhibit the DNA supercoiled relaxation mediated by human topoisomerase IB (TopIB), and complex 1 is found to be the most efficient TopIB inhibitor among the five compounds. The inhibitory effect and analysis of different steps of the TopIB catalytic cycle indicate that complex 1 inhibits the cleavage reaction impeding the binding of the enzyme to DNA and has no effect on the religation step. Complexes 1, 2 and 3 did not show mutagenic activity when they were evaluated by the cytokinesis-block micronucleus cytome assay in HepG2 cells and the Ames test in the presence and absence of mouse liver S9 metabolic activation. Therefore, it is necessary to perform further in-depth analysis of the therapeutic potential of these promising ruthenium complexes as anticancer drugs. Dipartimentodi Biologia Universit&#224;TorVergatadi Roma Departamento de Qu&#237;mica Universidade Federal de S&#227;o Carlos, CP 676 Departamento de Qu&#237;mica Universidade Federal de Ouro Preto Departamento de Ci&#234;ncias Biol&#243;gicas Faculdade de Ci&#234;ncias Farmac&#234;uticas UNESP Instituto de F&#237;sica Universidade DeS&#227;o Paulo, CP 369 Instituto de Qu&#237;mica de S&#227;o Carlos Universidade de S&#227;o Paulo, CP 780 Departamento de Gerontologia Universidade Federal de S&#227;o Carlos, CP 676 Departamento de Ci&#234;ncias Biol&#243;gicas Faculdade de Ci&#234;ncias Farmac&#234;uticas UNESP

Details

ISSN :
14779234 and 14779226
Volume :
48
Database :
OpenAIRE
Journal :
Dalton Transactions
Accession number :
edsair.doi.dedup.....53d8fb2c32348bad8e09e44ff17a14c5
Full Text :
https://doi.org/10.1039/c9dt01905g